E-LIB Suche - Ergebnisse für: Lazzarin, A.

1

Bictegravir/emtricitabine/tenofovir alafenamide as initial ..:

Sax, PE ; Arribas, JR ; Orkin, C...
EClinicalMedicine. , 2023

Link: https://qmro.qmul.ac.uk/..

2

Hepatitis delta infection among persons living with HIV in ..:

Beguelin C ; Atkinson A ; Boyd A...
info:eu-repo/semantics/altIdentifier/pmid/36625770. , 2023

Link: https://hdl.handle.net/2..

3

Incidence of hypertension in people with HIV who are treate..:

Byonanebye D. M ; Polizzotto M. N ; Neesgaard B...
info:eu-repo/semantics/altIdentifier/wos/WOS:000762466900001. , 2022

Link: http://hdl.handle.net/11..

4

Switching from a Non-Protease Inhibitor-Based Regimen to th..:

Ranzenigo M ; Gianotti N ; Galli L...
https://www.dovepress.com/corrigendum-switching-from-a-non-protease-inhibitor-based-regimen-to-t-peer-reviewed-fulltext-article-DDDT. , 2022

Link: https://doaj.org/article..

5

Switching from a Non-Protease inhibitor-Based Regimen To th..:

Ranzenigo M ; Gianotti N ; Galli L...
https://www.dovepress.com/switching-from-a-non-protease-inhibitor-based-regimen-to-the-fixed-dos-peer-reviewed-fulltext-article-DDDT. , 2022

Link: https://doaj.org/article..

6

HCV reinfection after HCV therapy among HIV/HCV-coinfected ..:

Amele S ; Sandri A. K ; Rodger A...
info:eu-repo/semantics/altIdentifier/pmid/34882940. , 2022

Link: http://hdl.handle.net/11..

7

HBcAb Positivity Increases the Risk of Severe Hepatic Fibro..:

Malagnino V ; Cerva C ; Cingolani A...
info:eu-repo/semantics/altIdentifier/pmid/33447635. , 2021

Link: http://hdl.handle.net/11..

8

HBcAb Positivity Increases the Risk of Severe Hepatic Fibro..:

Vincenzo Malagnino ; Carlotta Cerva ; Antonella Cingolani...
info:eu-repo/semantics/altIdentifier/pmid/33447635. , 2021

Link: http://hdl.handle.net/11..

9

Clinical features and comorbidity pattern of HCV infected m..:

Quaranta M. G ; Ferrigno L ; Tata X...
info:eu-repo/semantics/altIdentifier/pmid/33893040. , 2021

Link: http://hdl.handle.net/11..

10

Clinical features and comorbidity pattern of HCV infected m..:

Quaranta M. G ; Ferrigno L ; Tata X...
info:eu-repo/semantics/altIdentifier/pmid/33893040. , 2021

Link: http://hdl.handle.net/11..

11

Publisher Correction: Viral clearance after early corticost..:

Spagnuolo, V ; Guffanti, M ; Galli, L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127505/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Clinical features and comorbidity pattern of HCV infected m..:

Quaranta M. G ; Ferrigno L ; Tata X...
info:eu-repo/semantics/altIdentifier/pmid/33893040. , 2021

Link: http://hdl.handle.net/10..

13

Publisher Correction: Viral clearance after early corticost..:

V. Spagnuolo ; M. Guffanti ; L. Galli...
https://doi.org/10.1038/s41598-021-89270-9. , 2021

Link: https://doi.org/10.1038/..

14

The impact of DAA-mediated HCV eradication on CD4+ and CD8+..:

Bandera A ; Lorenzini P ; Taramasso L...
info:eu-repo/semantics/altIdentifier/pmid/33600068. , 2021

Link: https://hdl.handle.net/1..

15

Laplacian eigenvalues of equivalent cographs:

Lazzarin, J ; Márquez, O. F ; Tura, F. C
http://arxiv.org/abs/2108.04873. , 2021

Link: http://arxiv.org/abs/210..